AP39 Free base
CAS No. 1429173-57-8
AP39 Free base( —— )
Catalog No. M34796 CAS No. 1429173-57-8
AP39 free base is a mitochondrial-targeted H(2)S donor that can improve the survival rate of porcine islets in culture.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 77 | In Stock |
|
| 10MG | 132 | In Stock |
|
| 25MG | 275 | In Stock |
|
| 50MG | 461 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAP39 Free base
-
NoteResearch use only, not for human use.
-
Brief DescriptionAP39 free base is a mitochondrial-targeted H(2)S donor that can improve the survival rate of porcine islets in culture.
-
DescriptionAP39 free base is a mitochondrial-targeted H(2)S donor that can improve the survival rate of porcine islets in culture. AP39 free base regulates mitophagy through the AMPK-ULK1-FUNDC1 pathway, inhibits cell pyroptosis, and improves doxorubicin-induced myocardial fibrosis.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1429173-57-8
-
Formula Weight641.87
-
Molecular FormulaC37H38O2PS3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(OC=1C=CC(=CC1)C=2SSC(=S)C2)CCCCCCCCC[P+](C=3C=CC=CC3)(C=4C=CC=CC4)C=5C=CC=CC5
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Triptorelin acetate(...
Triptorelin Acetate is used as a GnRH agonist. It decreases pituitary secretion of gonadotropins luteinizing hormone (LH) and follicle-stimulating hormone (FSH) by causing constant stimulation of the pituitary.
-
Remimazolam
Remimazolam is a benzodiazepine derivative drug as an alternative to the short-acting imidazobenzodiazepine midazolam, for use in induction of anaesthesia and conscious sedation for minor invasive procedures.?Remimazolam was found to be both faster acting and shorter lasting than midazolam, and human clinical trials showed a faster recovery time and predictable, consistent pharmacokinetics, suggesting some advantages over existing drugs for these applications.?
-
FTIDC
FTIDC is a highly potent and selective allosteric antagonist of mGluR1 receptors and shows very weak potency against human and rat mGluR5 receptors.
Cart
sales@molnova.com